Author： Lenz T.L. Wilson A.F.
Publisher： Adis International
ISSN： 0312-5963
Source： Clinical Pharmacokinetics, Vol.42, Iss.10, 2003-01, pp. : 909-920
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
A Benefit-Risk Assessment of Agents Used in the Secondary Prevention of Stroke
By MacWalter R.S. Shirley C.P.
Drug Safety, Vol. 25, Iss. 13, 2002-01 ,pp. :
Primary and Secondary Stroke Prevention with Antiplatelet Drugs
Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. :
Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke
CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. :